Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Unicycive Therapeutics Inc UNCY

Unicycive Therapeutics, Inc. is a biotechnology company that is developing treatments for certain medical conditions. Its programs are focused on kidney disease, an area that has the potential to offer medical benefits. Its development programs are focused on two novel therapies: Oxylanthanum Carbonate, and UNI 494. Oxylanthanum Carbonate is a novel investigational phosphate binding agent being... see more

NDAQ:UNCY - Post Discussion

Unicycive Therapeutics Inc > UNCY .....The trend continues....Day 6 of run....Sheesh
View:
Post by Iseneschal on Mar 10, 2023 9:04am

UNCY .....The trend continues....Day 6 of run....Sheesh

Close Prices Last 3 Months

Date Ex Sym Open High Low Close Chg Vol #Tr Bid Ask
2023-03-09 Q UNCY 1.91 2.24 1.76 2.06 0.44 46,695,686 51,175    
2023-03-08 Q UNCY 1.44 1.75 1.35 1.62 0.12 12,134,258 14,231    
2023-03-07 Q UNCY 1.46 2.16 1.37 1.50 0.26 89,437,509 103,573    
2023-03-06 Q UNCY 1.41 1.63 1.13 1.24 0.75 102,922,506 98,143    
2023-03-03 Q UNCY 0.511 0.52 0.48 0.49 -0.01 70,241 107
Comment by Iseneschal on Mar 10, 2023 9:07am
I failed to mention that my chart tells me there congestion at this level.....resistance start at ~ $2.32 Cheers
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities